Advances in SELEX and application of aptamers in the central nervous system

Biomolecular Engineering

Volumn 24, Issue 6, 2007, Pages 583-592

  Yang, Yan ^a   Yang, Dongliang ^a   Schluesener, Hermann J ^b   Zhang, Zhiren ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Aptamers; Central nervous system; SELEX

Indexed keywords

COMBINATORIAL OPTIMIZATION; ELECTROPHORESIS; LIGANDS; NEUROLOGY; PROTEINS;

APTAMERS; CENTRAL NERVOUS SYSTEM; COMBINATORIAL NUCLEIC ACID LIBRARY; MACULAR DEGENERATION; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT;

NUCLEIC ACIDS;

APTAMER; RNA; SINGLE STRANDED DNA;

ALZHEIMER DISEASE; BINDING AFFINITY; BIOSENSOR; BRAIN TUMOR; CAPILLARY ELECTROPHORESIS; CENTRAL NERVOUS SYSTEM DISEASE; COMBINATORIAL CHEMISTRY; COMBINATORIAL LIBRARY; DRUG DEPENDENCE; FOOD AND DRUG ADMINISTRATION; MYASTHENIA GRAVIS; PRION DISEASE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW;

ALZHEIMER DISEASE; APTAMERS, NUCLEOTIDE; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM; ELECTROPHORESIS, CAPILLARY; HUMANS; MYASTHENIA GRAVIS; PRION DISEASES; SELEX APTAMER TECHNIQUE; SUBSTANCE-RELATED DISORDERS;

EID: 36248951185     PISSN: 13890344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bioeng.2007.06.003     Document Type: Review

References (66)

1. Berezovski M.V., Musheev M.U., Drabovich A.P., Jitkova J.V., and Krylov S.N. Non-SELEX: selection of aptamers without intermediate amplification of candidate oligonucleotides. Nat. Protoc. 1 (2006) 1359-1369
2. Bischoff A., and Michel M.C. Emerging functions for neuropeptide Y5 receptors. Trends Pharmacol. Sci. 20 (1999) 104-106
3. Brockstedt U., Uzaroeska A., Montpetit A., Pfau W., and Labuda D. In vitro evolution of RNA aptamers recognizing carcinogenic aromatic amines. Biochem. Biophys. Res. Commun. 313 (2003) 1004-1008
4. Bunka D.H., and Stockley P.G. Aptamers come of age- at last. Nat. Rev. Microbiol. 4 (2006) 588-596
5. Calo G., Bigoni R., Rizzi A., Guerrini R., Salvadori S., and Regoli D. Nociceptin/orphanin FQ receptor ligands. Peptides 21 (2000) 935-947
6. Calo G., Rizzi A., Bigoni R., Guerrini R., Salvadori S., and Regoli D. Pharmacological profile of nociceptin/orphanin FQ receptors. Clin. Exp. Pharmacol. Physiol. 29 (2002) 223-228
7. Cao Z., and Tan W. Molecular aptamers for real-time protein-protein interaction study. Chemistry 11 (2005) 4502-4508
8. Centi S., Tombelli S., Minunni M., and Mascini M. Aptamer-based detection of plasma proteins by an electrochemical assay coupled to magnetic beads. Anal. Chem. 79 (2007) 1466-1473
9. Cerchia L., Duconge F., Pestourie C., Boulay J., Aissouni Y., Gombert K., Tavitian B., de Franciscis V., and Libri D. Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase. PLoS Biol. 3 (2005) e123
10. Cerchia L., D'Alessio A., Amabile G., Duconge F., Pestourie C., Tavitian B., Libri D., and de Franciscis V. An autocrine loop involving ret and glial cell-derived neurotrophic factor mediates retinoic acid-induced neuroblastoma cell differentiation. Mol. Cancer Res. 4 (2006) 481-488
11. Chaloin L., Lehmann M.J., Sczakiel G., and Restle T. Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1. Nucleic Acids Res. 30 (2002) 4001-4008
12. Charlton J., Sennello J., and Smith D. In vivo imaging of inflammation using an aptamer inhibitor of human neutrophil elastase. Chem. Biol. 4 (1997) 809-816
13. Cox J.C., and Ellington A.D. Automated selection of anti-protein aptamers. Bioorg. Med. Chem. 9 (2001) 2525-2531
14. Cox J.C., Hayhurst A., Hesselberth J., Bayer T.S., Georgiou G., and Ellington A.D. Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer. Nucleic Acids Res. 30 (2002) e108
15. Cui Y., Ulrich H., and Hess G.P. Selection of 2′-fluoro-modified RNA aptamers for alleviation of cocaine and MK-801 inhibition of the nicotinic acetylcholine receptor. J. Membr. Biol. 202 (2004) 137-149
16. Daniels D.A., Sohal A.K., Rees S., and Grisshammer R. Generation of RNA aptamers to the G-protein-coupled receptor for neurotensin, NTS-1. Anal. Biochem. 305 (2002) 214-226
17. Daniels D.A., Chen H., Hicke B.J., Swiderek K.M., and Gold L. A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. PNAS 100 (2003) 15416-15421
18. Drabovich A., Berezovski M., and Krylov S.N. Selection of smart aptamers by equilibrium capillary electrophoresis of equilibrium mixtures (ECEEM). J. Am. Chem. Soc. 127 (2005) 11224-11225
19. Drachman D.B. Myasthenia gravis. N. Engl. J. Med. 330 (1994) 1797-1810
20. Ellington A.D., and Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature 346 (1990) 818-822
21. Erickson H.P., and Bourdon M.A. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu. Rev. Cell Biol. 5 (1989) 71-92
22. Eulberg D., Buchner K., Maasch C., and Klussmann S. Development of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonist. Nucleic Acids Res. 33 (2005) e45
23. Faulhammer D., Eschgfaller B., Stark S., Burgstaller P., Englberger W., Erfurth J., Kleinjung F., Rupp J., Dan Vulcu S., Schroder W., Vonhoff S., Nawrath H., Gillen C., and Klussmann S. Biostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQ. RNA 10 (2004) 516-527
24. German I., Buchanan D.D., and Kennedy R.T. Aptamers as ligands in affinity probe capillary electrophoresis. Anal. Chem. 70 (1998) 4540-4545
25. Golden M.C., Collins B.D., Willis M.C., and Koch T.H. Diagnostic potential of PhotoSELEX-evolved ssDNA aptamers. J. Biotechnol. 81 (2000) 167-178
26. Gopinath S.C., Shikamoto Y., Mizuno H., and Kumar P.K. A potent anti-coagulant RNA aptamer inhibits blood coagulation by specifically blocking the extrinsic clotting pathway. Thromb. Haemost. 95 (2006) 767-771
27. Heckel A., and Mayer G. Light regulation of aptamer activity: an anti-thrombin aptamer with caged thymidine nucleobases. J. Am. Chem. Soc. 127 (2005) 822-823
28. Held D.M., Kissel J.D., Patterson J.T., Nickens D.G., and Burke D.H. HIV-1 inactivation by nucleic acid aptamers. Front. Biosci. 11 (2006) 89-112
29. Hicke B.J., Marion C., and Chang Y.F. Tenascin-C aptamers are generated using tumor cells and purified protein. J. Biol. Chem. 276 (2001) 48644-48654
30. Huang C.C., Cao Z., Chang H.T., and Tan W. Protein-protein interaction studies based on molecular aptamers by affinity capillary electrophoresis. Anal. Chem. 76 (2004) 6973-6981
31. Hussein M.F., and Al-Mufarrej S.I. Prion diseases: a review II. Prion diseases in man and animals. Sci. J. King Faisal University 5 (2004) 139-166 (Basic and Applied Sciences)
32. Hwang J., and Nishikawa S. Novel approach to analyzing RNA aptamer-protein interactions: toward further applications of aptamers. J. Biomol. Screen. 11 (2006) 599-605
33. Hybarger G., Bynum J., Williams R.F., Valdes J.J., and Chambers J.P. A microfluidic SELEX prototype. Anal. Bioanal. Chem. 384 (2006) 191-198
34. Jarosch F., Buchner K., and Klussmann S. In vitro selection using a dual RNA library that allows primerless selection. Nucleic Acids Res. 34 (2006) e86
35. Jayasena S.D. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin. Chem. 45 (1999) 1628-1650
36. Koch T.H., Smith D., Tabacman E., and Zichi D.A. Kinetic analysis of site-specific photoaptamer-protein cross-linking. J. Mol. Biol. 336 (2004) 1159-1173
37. Lee S.W., and Sullenger B.A. Isolation of a nuclease-resistant decoy RNA that can protect human acetylcholine receptors from myasthenic antibodies. Nat. Biotechnol. 15 (1997) 41-45
38. Loftus T.M., Jaworsky D.E., Frehywot G.L., Townsend C.A., Ronnett G.V., Lane M.D., and Kuhajda F.P. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288 (2000) 2379-2381
39. Martell R.E., Nevins J.R., and Sullenger B.A. Optimizing aptamer activity for gene therapy applications using expression cassette SELEX. Mol. Ther. 6 (2002) 30-34
40. Mayer G., Kruvk L., Mikat V., Engeser M., and Heckel A. Light-induced formation of G-quadruplex DNA secondary structures. Chem. Biochem. 6 (2005) 1966-1970
41. Mendonsa S.D., and Bowser M. In vitro evolution of functional DNA using capillary electrophoresis. J. Am. Chem. Soc. 126 (2004) 20-21
42. Mendonsa S.D., and Bowser M. In vitro selection of high-affinity DNA ligands for human IgE using capillary electrophoresis. Anal. Chem. 76 (2004) 5387-5392
43. Mendonsa S.D., and Bowser M. In vitro selection of aptamers with affinity for neuropeptide Y using capillary electrophoresis. J. Am. Chem Soc. 127 (2005) 9382-9383
44. Mercey R., Lantier I., Maurel M.C., Grosclaude J., Lantier F., and Marc D. Fast, reversible interaction of prion protein with RNA aptamers containing specific sequence patterns. Arch. Virol. 151 (2006) 2197-2214
45. Proske D., Hofliger M., Soll R.M., Beck-Sickinger A.G., and Famulok M. A Y2 receptor mimetic aptamer directed against neuropeptide Y. J. Biol. Chem. 277 (2002) 11416-11422
46. Proske D., Gilch S., Wopfner F., Schatzl H.M., Winnacker E.L., and Famulok M. Prion-protein-specific aptamer reduces PrPSc formation. Chem. Biochem 3 (2002) 717-725
47. Que-Gewirth N.S., and Sullenger B.A. Gene therapy progress and prospects: RNA aptamers. Gene Ther. 14 (2007) 283-291
48. Rentmeister A., Bill A., Wahle T., Walter J., and Famulok M. RNA aptamers selectively modulate protein recruitment to the cytoplasmic domain of beta-secretase BACE1 in vitro. RNA 12 (2006) 1650-1660
49. Rhie A., Kirby L., Sayer N., Wellesley R., Disterer P., Sylvester I., Gill A., Hope J., James W., and Tahiri-Alaoui A. Characterisation of 2′-fluoro-RNA aptamers that bind preferentially to diseaseassociated conformations of prion protein and inhibition conversion. J. Biol. Chem. 278 (2003) 39697-39705
50. Romig T.S., Bell C., and Drolet D.W. Aptamer affinity chromatography: combinatorial chemistry applied to protein purification. J. Chromatogr. 731 (1999) 275-284
51. Sayer N., Cubin M., Rhie A., Bullock M., Tahiri-Alaoui A., and James W. Structural determinants of conformationally selective, prion-binding aptamers. J. Biol. Chem. 279 (2004) 13102-13109
52. Seiwert S.D., Nahreini T.S., Aigner S., Ahn N.G., and Uhlenbeck O.C. RNA aptamers as pathway-specific MAP kinase inhibitors. Chem. Biol. 7 (2000) 833-843
53. Sekiya S., Noda K., Nishikawa F., Yokoyama T., Kumar P.K.R., and Nishikawa S. Characterization and application of a novel RNA aptamer against the mouse prion protein. J. Biochem. 139 (2006) 383-390
54. Seo H.S., and Lee S.W. In vitro selection of the 2′-fluoro-2′-deoxyribonucleotide decoy RNA inhibitor of myasthenia autoantibodies. J. Microbiol. Biotechnol. 10 (2000) 7070-7073
55. Stojanovic M.N., and Kolpashchikov D.M. Modular aptameric sensors. J. Am. Chem. Soc. 126 (2004) 9226-9270
56. Takemura K., Wang P., Vorberg I., Surewicz W., Priola S., Kanthasamy A., Pottathil R., Chen S., and Sreevatsan S. DNA aptamers that bind to PrPC and Not PrPSc show sequence and structure specificity. Exp. Biol. Med. 231 (2006) 204-214
57. Tu D., Blaha G., Moore P.B., and Steitz T.A. Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance. Cell 121 (2005) 257-270
58. Tuerk C., and Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA-polymerase. Science 249 (1990) 505-510
59. Ulrich H., Ippolito J.E., Pagan O.R., Eterovic V.A., Hann R.M., Shi H., Lis J.T., Eldefrawi M.E., and Hess G.P. In vitro selection of RNA molecules that displace cocaine from the membrane-bound nicotinic acetylcholine receptor. PNAS 95 (1998) 14051-14056
60. Varghese J.N., Epa V.C., and Colman P.M. Three dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase. Protein Sci. 4 (1995) 1081-1087
61. Vater A., Jarosch F., Buchner K., and Klussmann S. Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEX. Nucleic Acids Res. 31 (2003) e130
62. Vivekananda J., and Kiel J.L. Anti-Francisella tularensis DNA aptamers detect tularemia antigen from different subspecies by aptamer-linked immobilized sorbent assay. Lab. Invest. 86 (2006) 610-618
63. Wang X.L., Li F., Su Y.H., Sun X., Li X.B., Schluesener H.J., Tang F., and Xu S.Q. Ultrasensitive detection of protein using an aptamer-based exonuclease protection assay. Anal. Chem. 76 (2004) 5605-5610
64. Weiss S., Proske D., Neumann M., Groschup M.H., Kretzschmar H.A., Famulok M., and Winnacker E.L. RNA aptamers specifically interact with the prion protein PrP. J. Virol. 71 (1997) 8790-8797
65. Wen J.D., and Gray D.M. Selection of genomic sequences that bind tightly to Ff gene 5 protein: primer-free genomic SELEX. Nucleic Acids Res. 32 (2004) e182
66. White R., Rusconi C., Scardino E., Wolberg A., Lawson J., Hoffman M., and Sullenger B. Generation of species cross-reactive aptamers using "toggle" SELEX. Mol. Ther. 4 (2001) 567-573